BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 338390)

  • 1. A controlled trial of baclofen in children with cerebral palsy.
    Milla PJ; Jackson AD
    J Int Med Res; 1977; 5(6):398-404. PubMed ID: 338390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal baclofen for spasticity in cerebral palsy.
    Albright AL; Cervi A; Singletary J
    JAMA; 1991 Mar; 265(11):1418-22. PubMed ID: 1999883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baclofen for spasticity in multiple sclerosis. Double-blind crossover and three-year study.
    Feldman RG; Kelly-Hayes M; Conomy JP; Foley JM
    Neurology; 1978 Nov; 28(11):1094-8. PubMed ID: 362234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baclofen in spasticity.
    Lancet; 1977 Sep; 2(8038):594-5. PubMed ID: 71406
    [No Abstract]   [Full Text] [Related]  

  • 5. Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin.
    Armstrong RW; Steinbok P; Cochrane DD; Kube SD; Fife SE; Farrell K
    J Neurosurg; 1997 Sep; 87(3):409-14. PubMed ID: 9285607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal baclofen for intractable cerebral spasticity: a prospective placebo-controlled, double-blind study.
    Van Schaeybroeck P; Nuttin B; Lagae L; Schrijvers E; Borghgraef C; Feys P
    Neurosurgery; 2000 Mar; 46(3):603-9; discussion 609-12. PubMed ID: 10719857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Oral Baclofen in the Treatment of Spasticity in Children and Adolescents With Cerebral Palsy.
    Navarrete-Opazo AA; Gonzalez W; Nahuelhual P
    Arch Phys Med Rehabil; 2016 Apr; 97(4):604-618. PubMed ID: 26321489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baclofen, a new antispastic drug. A controlled, multicenter trial in patients with multiple sclerosis.
    Sachais BA; Logue JN; Carey MS
    Arch Neurol; 1977 Jul; 34(7):422-8. PubMed ID: 327987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of lioresal on the rehabilitation of spastics].
    Gusta A; Matwiejko L; Pienc A
    Chir Narzadow Ruchu Ortop Pol; 1977; 42(2):193-7. PubMed ID: 891318
    [No Abstract]   [Full Text] [Related]  

  • 10. Clonazepam, baclofen and placebo in the treatment of spasticity.
    Cendrowski W; Sobczyk W
    Eur Neurol; 1977; 16(1-6):257-62. PubMed ID: 354938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term therapy with intrathecal baclofen improves quality of life in children with severe spastic cerebral palsy.
    Kraus T; Gegenleitner K; Svehlik M; Novak M; Steinwender G; Singer G
    Eur J Paediatr Neurol; 2017 May; 21(3):565-569. PubMed ID: 28237420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral baclofen in children with cerebral palsy: a double-blind cross-over pilot study.
    Scheinberg A; Hall K; Lam LT; O'Flaherty S
    J Paediatr Child Health; 2006 Nov; 42(11):715-20. PubMed ID: 17044900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baclofen (Lioresal) in the treatment ofneuroleptic-induced tardive dyskinesia.
    Korsgaard S
    Acta Psychiatr Scand; 1976 Jul; 54(1):17-24. PubMed ID: 782159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacloffen (Lioresal) in the long-term management of spasticity.
    Jones RF; Lance JW
    Med J Aust; 1976 May; 1(18):654-7. PubMed ID: 820953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal baclofen therapy in children with cerebral palsy.
    Brown TR
    Arch Phys Med Rehabil; 2003 Apr; 84(4):624; author reply 624. PubMed ID: 12690609
    [No Abstract]   [Full Text] [Related]  

  • 16. Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial.
    Gilmartin R; Bruce D; Storrs BB; Abbott R; Krach L; Ward J; Bloom K; Brooks WH; Johnson DL; Madsen JR; McLaughlin JF; Nadell J
    J Child Neurol; 2000 Feb; 15(2):71-7. PubMed ID: 10695888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of therapeutic response to baclofen vs tolperisone in spasticity.
    Agarwal S; Patel T; Shah N; Patel BM
    Biomed Pharmacother; 2017 Mar; 87():628-635. PubMed ID: 28086137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy. AACPDM Treatment Outcomes Committee Review Panel.
    Butler C; Campbell S
    Dev Med Child Neurol; 2000 Sep; 42(9):634-45. PubMed ID: 11034458
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of baclofen in treatment of spasticity in multiple sclerosis.
    Sawa GM; Paty DW
    Can J Neurol Sci; 1979 Aug; 6(3):351-4. PubMed ID: 385132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical practices in intrathecal baclofen pump implantation in children with cerebral palsy in France.
    Mietton C; Nuti C; Dohin B; Bayle B; Fernandez B; Poirot I; Gautheron V; Vuillerot C
    Ann Phys Rehabil Med; 2016 Sep; 59(4):282-4. PubMed ID: 27158102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.